chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the rash occurred after the second vaccine, started two days sooner; This is a spontaneous report from a contactable consumer (patient). A 22 years old non-pregnant female patient received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unspecified date as Dose 2, Single for covid-19 immunization at Health Clinic. The patient's medical history included known allergies to sulfa drugs, ceclor, amoxicillin. The patient's concomitant medications included ethinylestradiol, norgestimate (TRI FEMYNOR) within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not diagnosed with covid prior vaccination. Since the vaccination, the patient had been tested for COVID-19 with negative result. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 13:30 (at the age of 22-year-old) as Dose 1, Single for Covid-19 immunization and experienced rash on thighs, calves, buttocks, the rash occurred after the second vaccine, started two days sooner. The rash recurrence after the second vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 18Apr2021 (post vaccination). The patient received treatment for resulted event. The outcome of event was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
PT WAS SO FATIGUED THAT HE SLEPT ALL DAY THURSDAY AND FRIDAY.
Dose 1 9/1/2021, within a week, heart racing and irregular heartbeat and got a heart monitor for 14 days and Paroxysmal Supraventricular Tachycardia. Got metabolic check and my fasting blood sugar was 135 by Sept 22, fasting blood sugar dropped to 78 which is normal. BP for Sept and Oct/Nov 2021 was much higher up 140/94. Recently it normalized. 118/78 in Sept 2021 Onset Tachycardia, it's not as frequent now but previously I had it everyday but still happening. 177 heart beats /Wednesday before Thanksgiving. As a baby I had a mild heart murmur but had no issues. Everything is back to normal except for heart tachycardia. Still have to cardiologists in the future and may do an ultrasound in the future.
Pt states 04/08/2021 awaken by a rapid heartbeat, irregular (skipping beats/fluttering). 04/09/2021 Contact with Physician 14th Heart monitor no irregular signs seen, self checks continue per (Cardiologist) Reports since then once a month, couple days irregular palpations reporting (May, June) Continues to monitor.
Initial literature report received on 07 Dec 2009: This polymedicated patient with a medical history of osteoporosis, hyperlipidemia and depression was vaccinated with Influenza vaccine (manufacturer unknown) on an unspecified date. Two days later on an unspecified date the patient experienced severe pruritic vesiculobullous eruption in the legs, arms and lower abdomen. The rash began as a tiny pink papules that formed vesicles. Physical examination revealed symmetrically distributed discrete, pink papules, vesicles and bullae over the lower extremities, hands, forearms and lower abdomen with particular concentration on the medial surfaces on the calves. Microscopic examination of a biopsy from left calf revealed a subepidermal blistering process with neutrophils. Direct immunofluorescence revealed linear deposits of immunoglobulin A (negative IgG, IgM, C3 and fibrinogen) along the basement membrane zone. The patient continued to get new lesions despite taking diphenydramine and cetrizine as prescribed by the doctor. The patient did not experienced fever, chills, upper respiratory or gastrointestinal symptoms or mucous membrane involvement. The eruptions cleared after two courses of prednisolone followed by a mid-potency topical corticosteroid and did not reoccur.
Experiencing chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Experiencing chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 031120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Experiencing chills). At the time of the report, CHILLS (Experiencing chills) outcome was unknown.            No concomitant medications reported by investigator  No treatment medications provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
2d after vaccine, patient developed a bright red, edematous arm and eczema patches. R arm swelling resolved eczema has gotten worse and spread all over. R axilla and shoulder with some honey colored crust.
Patient had a hot/cold sensation. She felt both hot and cold at the same time. She had chills and felt "off." This occurred less than three minutes after receiving the Pfizer vaccine. These symptoms lasted for approximately 30 minutes. A couple of years ago she passed out after receiving the HPV vaccine.
Immediately flushed and hot with infection of Twinrix.  That passed and client complained of nausea and warm feeling for next 1 1/2 hours.
Information has been received from a pharmacist referring to a 60 years old female patient. The patient's concurrent condition, historical condition and drug reactions/allergies were not reported. On 18-JUN-2016 the patient was vaccinated with a dose of ZOSTAVAX (lot # M010486, expiration date 25-MAY-2017, dose not reported) subcutaneously. Concomitant therapy was not provided. On unknown dates in 2016 the patient experienced redness and swelling at the injection site. The patient did not seek any medical attention. No treatment was given for both events. The patient had not recovered from both events at the time of reporting. The pharmacist declined the varicella zoster virus (VZV) packet. Reporter's causality was not reported. Additional information has been requested.
Severe Headache, Eye swelling, throat swelling, Ear swelling, Arm swelling/redness, chills, sinus pressure, feeling like my thought and sight is "clouded".  Unable to think clearly.
Fever, Overwhelming Fatigue, Muscle/Body Aches  Lasted Until 4/23/2021.  Then I was fine.
Large erythematous of (L) thigh 6 1/2 in X 4 inch patch. Warm/hot to touch & itching. Treatment- BENADRYL, MOTRIN & ice pack.
arm was red; arm was hot; arm was swollen; there was a rash on their neck in the side where they got the vaccine with redness on it; itching a lot on their back and ear and the palm of their hand; very very tired, terribly fatigued; it was like a hive on their upper lip; ears started itching; threw up some liquid that night; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (it was like a hive on their upper lip), EAR PRURITUS (ears started itching), ERYTHEMA (arm was red), FEELING HOT (arm was hot) and PERIPHERAL SWELLING (arm was swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seafood allergy (shellfish), Seasonal allergy (Seasonal) and Allergy to plants (Christmas trees). Concomitant products included LISINOPRIL, FAMOTIDINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and PROBIOTICS NOS for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (it was like a hive on their upper lip), EAR PRURITUS (ears started itching) and VOMITING (threw up some liquid that night). On 22-Feb-2021, the patient experienced ERYTHEMA (arm was red), FEELING HOT (arm was hot), PERIPHERAL SWELLING (arm was swollen), RASH ERYTHEMATOUS (there was a rash on their neck in the side where they got the vaccine with redness on it), PRURITUS (itching a lot on their back and ear and the palm of their hand) and FATIGUE (very very tired, terribly fatigued). The patient was treated with SERTRALINE HYDROCHLORIDE ongoing since an unknown date at an unspecified dose and frequency. On 10-Feb-2021, VOMITING (threw up some liquid that night) had resolved. At the time of the report, URTICARIA (it was like a hive on their upper lip), EAR PRURITUS (ears started itching), ERYTHEMA (arm was red), FEELING HOT (arm was hot), PERIPHERAL SWELLING (arm was swollen), RASH ERYTHEMATOUS (there was a rash on their neck in the side where they got the vaccine with redness on it), PRURITUS (itching a lot on their back and ear and the palm of their hand) and FATIGUE (very very tired, terribly fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 10-Feb-2021, the patient took (Sertaline) 30 minutes before getting the vaccine.  Her doctor wanted her to have the Moderna vaccine since it was the least allergic one.  No other treatment was reported.   This case was linked to MOD-2021-028289 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of feeling tense in a 11-week-old female patient who received PEDIARIX. Co-suspect products included PEDIARIX. On 16th February 2016, the patient received the 1st dose of PEDIARIX. On 8th March 2016, the patient received the 2nd dose of PEDIARIX. On 16th February 2016, less than a day after receiving PEDIARIX and not applicable after receiving PEDIARIX, the patient experienced feeling tense and irritability. On 8th March 2016, the patient experienced drug dose administration interval too short, in March 2016, the patient experienced feeling tense and irritability. On 17th February 2016, the outcome of the feeling tense and irritability were recovered/resolved. On an unknown date, the outcome of the drug dose administration interval too short, feeling tense and irritability were unknown. The reporter considered the feeling tense and irritability to be related to PEDIARIX. Additional details provided were as follows: This case was reported by the patient's mother. This case was previously reported to a doctor. On 8th March 2016, the patient inadvertently received the 2nd dose of PEDIARIX vaccine 3 weeks after receiving the 1st dose. This led to the shortening of vaccination schedule. The patient's mother reported that, less than a month after vaccination with the 2nd dose the patient appeared to be fine, but was usual fussy and easily startled. The patient also experienced the similar events less than a day after receiving the 2st dose of the vaccine as well. She noted no fever for either administration. The patient's mother did not have any other details but states her daughter did receive other vaccines on those days as well.
Basic allergies; Had more energy first four hours after the shot; Second dose scheduled at day 43, patient has not received second dose yet; sore throat; Bad taste in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Bad taste in her mouth), ENERGY INCREASED (Had more energy first four hours after the shot), OROPHARYNGEAL PAIN (Sore throat), HYPERSENSITIVITY (Basic allergies) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.  Concomitant products included PANTOPRAZOLE and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced TASTE DISORDER (Bad taste in her mouth) and ENERGY INCREASED (Had more energy first four hours after the shot). On 02-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HYPERSENSITIVITY (Basic allergies). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at an unspecified dose and frequency. On 09-Mar-2021, ENERGY INCREASED (Had more energy first four hours after the shot) had resolved. On 23-Mar-2021, TASTE DISORDER (Bad taste in her mouth) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and HYPERSENSITIVITY (Basic allergies) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Seizure 9 days after receiving MMR, Prevnar and Varivax vaccinations.
On 7/11/2022 in the afternoon, I started very mild cold symptoms. Maybe sniffles and a sneeze or two. We were traveling at the time and I wore a mask the entire time traveling. I came home and felt a bit warm. I took my temperature and it was 99.7. That's why I tested and I was positive for COVID-19. Symptoms were just cold symptoms. They were a stuffy nose, no sore throat, but did have some tiredness. I slept a lot the first few days. I didn't think it was anything else other than a cold. That lasted 4-5 days and I was fine. I tested again on 7/19/2022 and I was still positive with a very faint line on the test. I tested negative on 7/21/2022 and I was clear. Also to add, during our time traveling, we were with a friend who was positive but we were outside. That's the only thing I can connect to how we got COVID-19. The only contact I had with a doctor was just to get prescribed PAXLOVID on 7/13/2022. That's when I started taking the medication.
ELEVATED HEART RATE; RASH ON THIGH; PERSISTENT FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the subject experienced elevated heart rate, rash on thigh, and persistent fever. Laboratory data (dates unspecified) included: Heart rate (NR: not provided) elevated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the rash on thigh, elevated heart rate and persistent fever was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Numbness of skin below injection site - sharp pain in subcutaneous area just below skin when extending arm fully.  Feels like something is ripping.
Shot administered at 2:30pm - patient complained of itching at site. Patient alert & speaking, gave patient 50mg. BENADRYL. Returned at 4:20pm - having trouble speaking - gave EPIPEN 0.3mg. Called EMS.
Vaccine exp. use by date = 10/7/22 8weeks follow defrost VS. Exp. date 10/31/2024
IgA deficiency and lactose intolerance. Saw allergist and ok'd admin of PNEUMOVAX and DTAP. Given 8/3/2015 PNEUMOVAX (L) deltoid DTAP (R) deltoid has had 5 cm redness and 3 cm induration (L) deltoid with fever up to 103 reported. 100.9 in office, pain in (L) arm, myalgias, arthralgias.
WHEN GIVEN PREVNAR 13 CHILD SCREAMED REALLY LOUD WAS HOLDING HER BREATH FOR LIKE 15 SECONDS AFTER THAT SHE BECAME DROWSY AND DROPPED HEAD FOR 15  SECONDS AND THEN MD WAS CALLED AT THAT POINT.  After arrival of MD, patient was picked up placed on table, eyes were open but still weak. Pt then started moving extremities, breathing and pulse regular.  After about 30 sec to 1 minute, pt was more alert and active again wtih good strenth in UE and LE.
Medical Assistant reports that 2 doses of GARDASIL-9 were given to a 25-year-old female over a span; No additional AE/; This spontaneous report was received from an other health professional and referred to a 25-year-old female patient. The patient's concomitant medications, pertinent medical history and drug reactions/allergies were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (2 doses, exact dose, strength, lot #, expiry date, anatomical location and route of administration were not provided) administered for prophylaxis over a span of 6 days (Inappropriate schedule of product administration). Reporter inquired if the patient should get a 3rdshot or for any recommendations on moving forward. Patient had no reactions/symptoms. No additional adverse event (AE) (No adverse event).
After getting the second Moderna vaccine, patient immediately claimed to be light-headed. I had the patient go to the floor and elevate his legs on the chair. I gave the patient a cold pack. He started feeling better after 15 minutes.
Information has been received from a consumer concerning an "about 70 year old" female friend who on an unknown date, was vaccinated with only one dose of 0.65ml ZOSTAVAX (Merck) (route and lot# not reported). The patient had pain throughout the arm of the injection after receiving ZOSTAVAX (Merck). The patient did not seek medical attention. At the time of reporting, the outcome was unknown. No further information is available.
fainting, followed by seizure like involuntary movement for 15 secs. patient regained consciousnees and left with family to healthcare providers.
A report has been received from a Physician concerning a 13 year old, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 18-Dec-2013. It was reported by Physician that eight patients were received expired FLUMIST QUADRIVALENT on 18-Dec-2013. The outcome of the event of received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
fever, chills, nausea, body aches, stiff neck. and tenderness at injection site
Patient was vaccinated in left deltoid with 0.5 mL of Janssen COVID-19 Vaccine Lot 204A21A.  Pt reported immediate and persisting sharp pain exactly where the needle went when he was vaccinated. Patient was very uncomfortable, grimacing, eyes squinted apparently from pain. We had him lay down on a cot and applied an ice pack to the site. BP 132/78, HR 84, PWD, PERRL, A&O, injection site looked normal.  Pt stated he had sort of thing happen after an influenza vaccine, and that the pain lasted 6 months. Patient reported his current pain as 2/10 compared to worst pain in life, and 2 or 3/10 compared to his previous experience(s?) of this. Pt had a sharp pain down his back (pt denied chest pains) that went away after about 20 seconds. A wrapped cold pack on the injection site seemed to help slightly, and he seemed to feel best when supporting his left arm with his right arm, and keeping his left arm still, adducted, and flexed with his left fist at his midline. Patient brought back to sitting upright on cot. He expressed pain when lifting his left arm upward. After a brief rest, he had less pain and could raise his left arm further before feeling significant pain.  Pt has history of shingles and has a gabapentin prescription. Pt works.  After 15 minutes pt felt a bit better, got up, and stated he didn't want to wait any longer and wanted to leave. MD on site suggested he switch from cold to applying heat this evening, to keep his arm moving though its full range, and that Tylenol or ibuprofen may help. Pt left with spouse.
SORE ARMS AT INJECTION SITE; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced sore arms at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arms at injection site on 10-APR-2021. This report was non-serious.
The first dose 6 months ago triggered after 12 hours 48 hours of high fever, very strong back pain preventing from sleeping one single minute 2 nights in a row, sciatica, muscle pains all over the body, strong headache, dizziness and fatigue. Tried everything against back pain: tylenol, diclofenac, menthol rub, icing, hot showers, back exercising, walking at night... nothing reduced the back pain The second dose today triggered the same symtoms but even worse and even faster after only 4 hours
Low fever; Headache; Nausea; Diarrhea; Severe muscle and bone pain; Severe muscle and bone pain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in left arm on 28Jan2021 11:00 at a single dose for COVID-19 immunization. Vaccination was done in a health clinic. Medical history included thrombocytosis Thrombocythemia, Polycythemia Vera, Neuropathy. The patient had non known allergies. Concomitant medication included apixaban (ELIQUIS), colecalciferol (D3), hydroxycarbamide (HYDREA), pregabalin (PREGABALIN) and venlafaxine hydrochloride (EFFEXOR). On 28Jan2021, the patient experienced headache, nausea, diarrhea, severe muscle and bone pain and low fever. The outcome of the events was recovering. The patient did not have COVID-19 prior to vaccination and was not tested for VOCID-19 after the vaccination. There was no treatment for the events.   Information on the lot/batch number has been requested.
First sign that appeared was soreness in the arm. This started approximately 2 hours after vaccination. By hour 4 after vaccination, the arm was so stiff that it was hard to move. At hour 6, the injection site was inspected for the first time. There was a bright red welt with an approximate 1 inch diameter; the welt was giving off a large amount of heat. The following morning, the welt had grown to approximately 2.5 inches in diameter. The arm was still extremely sore and difficult to move without pain. The soreness and pain went down as time went on. Today, five days after the vaccine, the welt is finally gone, but there is still residual muscle soreness.
Information has been received from a registered nurse concerning a female who on 23-JAN-2008 was vaccinated with a first dose of GARDASIL (lot number, injection site and route not reported).  On 09-JUN-2008 the patient was vaccinated with a second dose of GARDASIL (lot number, injection site and route not reported).  Subsequently the patient experienced pain and redness at the injection site.  Additional information has been requested.